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Abstract
Background
Diabetes mellitus (DM) is associated with a range of microvascular complications including
diabetic nephropathy (DN). Microvascular abnormalities in the kidneys are common histo-
pathologic findings in DN, which represent one manifestation of ongoing systemic microvas-
cular damage. Recently, sidestream dark-field (SDF) imaging has emerged as a noninvasive
tool that enables one to visualize the microcirculation. In this study, we investigated whether
changes in the systemic microvasculature induced by DM and an atherogenic diet correlated
spatiotemporally with renal damage.
Methods
Atherosclerotic lesion development was triggered in streptozotocin-induced DM pigs
(140 mg/kg body weight) by administering an atherogenic diet for approximately 11
months. Fifteen months following induction of DM, microvascular morphology was visual-
ized in control pigs (n = 7), non-diabetic pigs fed an atherogenic diet (ATH, n = 5), and DM
pigs fed an atherogenic diet (DM+ATH, n = 5) using SDF imaging of oral mucosal tissue.
Subsequently, kidneys were harvested from anethesized pigs and the expression levels
of well-established markers for microvascular integrity, such as Angiopoietin-1 (Angpt1)
and Angiopoietin-2 (Angpt2) were determined immunohistochemically, while endothelial
cell (EC) abundance was determined by immunostaining for von Willebrand factor (vWF).
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Results
Our study revealed an increase in the capillary tortuosity index in DM+ATH pigs (2.31±0.17)
as compared to the control groups (Controls 0.89±0.08 and ATH 1.55±0.11; p<0.05). Kid-
ney biopsies showed marked glomerular lesions consisting of mesangial expansion and
podocyte lesions. Furthermore, we observed a disturbed Angpt2/ Angpt1balance in the cor-
tex of the kidney, as evidenced by increased expression of Angpt2 in DM+ATH pigs as com-
pared to Control pigs (p<0.05).
Conclusion
In the setting of DM, atherogenesis leads to the augmentation of mucosal capillary tortuosi-
ty, indicative of systemic microvascular damage. Concomitantly, a dysbalance in renal
angiopoietins was correlated with the development of diabetic nephropathy. As such, our
studies strongly suggest that defects in the systemic microvasculature mirror the accumula-
tion of microvascular damage in the kidney.
Introduction
Diabetes mellitus (DM) is associated with macrovascular and microvascular complications that
lead to retinopathy, neuropathy and nephropathy. Diabetic nephropathy is the leading cause of
chronic kidney disease (CKD) worldwide [1,2]. In this disease setting, the combination of en-
dothelial dysfunction and an imbalanced angiogenic response play an important role in the de-
velopment of microvascular complications. Recently, the angiopoietins have gained much
attention as critical regulators of of diverse pathological angiogenic conditions, including vas-
cular complications associated with diabetes. The tight control of Angiopoietin-1 (Angpt1) and
Angiopoietin- 2 (Angpt2) levels is critical in minimizing microvascular derangements that are
the direct result of negative interference of Angpt2 with Angpt1-mediated Tie-2 signaling. This
in turn disturbs the expression levels of key angiogenic factors such as vonWillebrand factor
(vWF) and vascular endothelial growth factor (VEGF). The ensuing loss of EC-pericyte inter-
actions is responsible for destabilization of the capillary network and the loss of microvascular
integrity. [3,4, 5, 6].
Histopathological findings in patients with diabetic nephropathy (DN) include mesangial
expansion, mesangial sclerosis and vascular lesions such as hyalinosis [7]. These renal abnor-
malities could potentially be indicative of the systemic microvascular damage [8]. However, the
detection of such pathophysiologies in DN is complex, as it is asymptomatic in early stages,
while at later stages the direct demonstration of renal injury requires renal biopsy material,
which is an unattractive tool for screening purposes due to the invasive nature of the proce-
dure. Therefore, methods geared towards the non-invasive monitoring for early signs of micro-
vascular changes is of clinical importance in patients with DM. However, at present these tools
do not exist. Sidestream dark-field (SDF) imaging is a relatively new, non-invasive tool that en-
ables one to visualize the microcirculation without the use of fluorescent dyes [9]. Recently, we
used this apparatus to assess labial mucosal capillary tortuosity and density in diabetic patients
compared with healthy non-diabetic controls, studies that revealed increased capillary density
and tortuosity in diabetic patients [10]. These studies focused on the effects of prolonged diabe-
tes in patients (24 ± 14 years). However, at present there is limited data regarding how distur-
bance of the microvasculature in early diabetes correlates with renal damage.
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In light of these considerations, we sought to investigate whether an atherogenic diet in the
early stages of DM could accelerate microvascular disease, and could serve as a diagnostic tool
for DM-induced renal damage. Using SDF imaging, we show that an atherogenic diet during
the early stages of DM leads to microvascular abnormalities, and immunohistochemically con-
firm that these systemic effects are associated with renal endothelial dysfunction, as evidenced
by a disturbed Angpt2/Angpt1 balance and microalbuminuria.
Materials and Methods
Animal experiments
The experimental protocol was performed in compliance with the ARRIVE guidelines on ani-
mal research [11]. Protocols describing the management, surgical procedures, and animal care
were reviewed and approved by the ASG-Lelystad Animal Care and Use Committee (Lelystad,
The Netherlands) and by the Institutional Review Board for animal experimentation of the
Erasmus University Medical Center (Rotterdam, The Netherlands). Ten neutered male domes-
tic pigs (Landrace x Yorkshire, T-line) with an age ~11 weeks and a body weight of ~30 kg en-
tered the study. After one week of acclimatization, DM was induced in a subgroup of 5 pigs by
slow intravenous injection of streptozotocin (STZ 140 mg/kg; Enzo Life Sciences, Raams-
donkveer, The Netherlands) as described previously [12–15]. Five non-diabetic pigs received
placebo treatment. Three weeks after DM induction, all of the pigs were gradually introduced
to an atherogenic diet (ATH), containing 25% of saturated fats and 1% of cholesterol [16]. The
5 diabetic pigs (DM+ATH) and 5 non-diabetic pigs (ATH) were subsequently followed for up
to 15 months, during which similar growth patterns were observed in both groups by adjusting
individual caloric intake. In the diabetic pigs, glucose and ketone levels in plasma and urine
were regularly checked in the 15-month follow-up period. Insulin therapy was started only in
instances where plasma ketones were detected. Following 12 months, 24h urine samples were
obtained from all pigs, while microcirculatory imaging and plasma samples were obtained
from anesthetized pigs (20mg/kg ketamine + 1 mg/kg midazolam+ 1 mg atropine, i.m. and
12mg/kg thiopental, i.v.) at 14 and 15 months of follow up, respectively. At 15 months, the pigs
were sacrificed by intravenous injection of an overdose of pentobarbital via the jugular vein
catheter at 15 months, at which point plasma samples were obtained and the kidneys were har-
vested for histological examination. Invasive imaging analyses prompted us to choose this time
frame as after 12 months of follow up more complex atherosclerotic lesions were present in the
coronary arteries of the studied pigs [23].
In addition, we also studied a separate control group (Controls) of 7 female domestic pigs
(Landrace) at the age of 5 months with a body weight of ~78 kg, who were fed a standard diet
for growing pigs.
Microcirculatory imaging and analysis of SDF measurements
SDF microscanning (MicroVision Medical Inc., Wallingford, PA, U.S.A) and analysis of im-
ages was performed as described earlier with minor modifications [10,16]. Anaesthetized pigs
were imaged at 14 months of study duration. All pigs were studied during standardized condi-
tions of general anesthesia by a trained observer.
Laboratory assessment
Serum Angpt1 and Angpt2 concentrations were measured after 12 months by enzyme-linked
immunosorbent assay (ELISA) (Bioconnect, Huissen, The Netherlands and Antibodies-online,
Atlanta, USA).
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At 12 months, protein and creatinine levels were measured in 24h urine samples. To calcu-
late the urinary albumin-creatinine ratio, we measured albumin excretion by ELISA (ITK diag-
nostics, Uithoorn, The Netherlands), and urinary creatinine concentration was measured by
standard laboratory methods. Both the plasma and urinary creatinine levels were measured as
previously described.
Plasma samples collected at 15 months were used to measure concentrations of glucose,
total cholesterol, triglycerides and low and high-density lipoproteins (LDL and HDL) and cre-
atinine by standardized methods at the clinical chemical laboratory of the Erasmus Medical
Center (Rotterdam, The Netherlands). In the absence of an established mathematical formula
to estimate creatinine clearance in pigs, we expressed creatinine levels in μmol/L/kg to adjust
for body weight. Blood collection tubes were centrifuged for 10 minutes at 3000 rpm after
which serum was stored in microcentrifuge tubes at -20°C until required for analysis.
Histological analysis of the kidney
Immunohistochemical analyses of snap-frozen porcine kidney cortex sections (4 μm) were air-
dried and acetone fixed as previously described [17]. Monoclonal antibodies utilized were di-
rected against mouse anti-human Angpt1 (clone 171718; R&D Systems, Abingdon, UK),
mouse anti-human VEGF (sc-7269 Santa Cruz Biotechnology, Huissen, the Netherlands) and
mouse anti-human plasminogen activator inhibitor-1 (clone HD-PAI-1 14.1) (American Diag-
nostica, Pfungstadt, Germany). Polyclonal antibodies were used directed against goat anti-
mouse Angpt2 (clone F18; sc-7017; Santa Cruz Biotechnology, Huissen, the Netherlands) and
rabbit anti-human vWF (Codenr A0082; Dako, Glostrum, Germany). Primary antibody bind-
ing was detected using the following isotype-matching secondary horseradish peroxidase
(HRP)-labeled antibodies; goat anti-mouse IgG (Angpt1), rabbit anti-goat IgG (Angpt2), anti-
mouse Envision K4007 (VEGF) or goat anti-rabbit IgG (vWF) (all purchased from Dako, Glos-
trum, Germany). Quantification of immunohistochemistry was performed in a blinded man-
ner by assessing 10 consecutive high power fields (magnification, ×200) using Image J
software. Glomerular and large vessels were excluded from analysis. For VEGF-A quantifica-
tion, 15 consecutive glomeruli per subject were selected and the percentage of VEGF-A positive
area was calculated using Image J.
Data are presented in terms of the Angpt2/Angpt1 ratio as previously described[18,19].
Immuofluorescent double stainings were performed for desmin (pericyte marker; mouse anti-
pig clone DE-B-5; Millipore, Amsterdam, the Netherlands)/Angpt1 (goat anti-human; clone
N-18; sc-6319; Santa Cruz Biotechnology, Huissen, the Netherlands) and vWF/Angpt2. Sec-
ondary antibodies were Alexa-488 labeled donkey anti- rabbit (vWF) and alexa-546 labelled
rabbit anti-mouse (desmin), Furthermore, HRP labelled rabbit anti-goat (Angpt1) and donkey
anti-goat (Angpt2) were used. Nuclei were visualized using Hoechst (Molecular Probes, Leiden,
the Netherlands). Photomicrographs were made using a fluorescence microscope (DM5500B;
Leica, Rijswijk, the Netherlands).
Next, we performed periodic acid-Schiff (PAS) staining on paraffin sections of renal cortex
for the evaluation of histopathological changes and morphometric analysis of the glomeruli. In
a blinded fashion, 25 consecutive glomeruli were selected from both superficial and deep cortex
and the mesangial expansion index was scored. Subsequently, we determined the extent of in-
crease in mesangial matrix (defined as mesangial area) by quantitating PAS-positive and nu-
clei-free areas in the mesangium using Image J [20,21]. Evaluation of histopathological lesions
was performed by a pathologist who was blinded to the code of the sections.
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Electron microscopy
Kidney tissues for electron microscopy were processed as described previously [22]. In typical
cases from the ATH and DM+ATH groups, the glomerular basement membrane (GBM) width
was measured.
RNA isolation and Real-Time PCR
To analyze renal Angpt1 and Angpt2 mRNA levels, RT-PCR was performed as described pre-
viously [23]. Expression was normalized against β-actin mRNA levels. RT-PCR analysis for bi-
ological replicates was performed in duplicate. The primer sequences were as follows: β-actin
(forward 5’-ATCGTGCGGGACATCAAGGA-3’ and reverse 5’-AGGAAGGAGGGCTGG-AA
GAG-3’), Angpt1 (forward 5’-AGGAGCAAGTTTTGCGAGAG-3’ and reverse 5’-CTCA-GA
GCGTTTGTGTTGT-3’) and Angpt2 (forward 5’-AAAGTTGCTGCAGGGAA-AGA-3’ and
reverse 5’-TCACAGCTCAGAGCGAAGAA-3’).
Statistical analysis
All data are presented as mean ± standard error of the mean (SEM). Differences between ex-
perimental groups were analyzed using one way-analysis of variance followed by post-hoc test-
ing with an unpaired Student’s t-test. Analyses were performed with GraphPad software
(GraphPad Software Inc., San Diego, CA, U.S.A.). P-values less than 0.05 (two-tailed) were
considered statistically significant.
Results
Model characteristics
Initial plasma profiling of DM+ATH and ATH pigs revealed that DM significantly influenced
glucose levels (17.64 ± 4.54 mmol/L vs. 5.12±0.42 mmol/L; p<0.05) (Table 1) at 15 months.
Total cholesterol, triglycerides, HDL and LDL were not significantly affected by the induction
of DM in pigs. Two pigs were administered insulin during the study period due to elevated
plasma ketone levels. The mean body weight at the time of microvascular imaging was compa-
rable between DM+ATH (96±2.8kg) and ATH group (93±0.4kg, p>0.05). At the time of sacri-
fice, substantial coronary lesions as well as generalised atherosclerosis for example in the aorta
were observed in both DM+ATH and ATH groups, as described previously [24].
Table 1. Model characteristics at 15 months of follow up.
Controls (N = 7) ATH (N = 5) DM+ATH (N = 5)
Glucose (mmol/l) 4.26±0.29 5.12±0.42 17.64±4.54*#
Triglycerides (mmol/l) 0.18±0.02 0.64±0.2 1.26±0.50*
Total Cholesterol (mmol/l) 1.50±0.05 18.10±2.66* 16.82±1.72*
LDL (mmol/l) 0.76±0.29 14.87±2.45* 13.63±1.3*
HDL (mmol/l) 0.60±0.03 5.70±0.35* 5.12±0.40*
All data are mean ±SEM. ATH: pigs on atherogenic diet. DM+ATH: pigs with diabetes mellitus on atherogenic diet. Controls: healthy control pigs on a
standard diet. LDL: Low density lipoprotein. HDL: High density lipoprotein.
* P<0.05 compared with Controls.
#P<0.05 compared with ATH pigs.
doi:10.1371/journal.pone.0121555.t001
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Early atherogenic diabetes mellitus leads to systemic microvascular
damage
The microvascular morphology of the oral mucosal tissue in DM+ATH pigs was significantly
disturbed as compared with the Controls (Fig 1A). Indeed, the capillary tortuosity index was sig-
nificantly increased in DM+ATH pigs (2.3±0.2) as compared with ATH pigs (1.6±0.1, p<0.01;
Fig 1B). Furthermore, capillary density was significant lower in the DM+ATH (18.6 ±1.3
capillaries/mm2) pigs as compared with the Controls (24.9 ±0.8 capillaries/mm2, p<0.01; Fig
1C).
Renal damage after induction of atherogenic DM in pigs
Plasma creatinine levels were elevated in ATH pigs (2.12±0.03 μmol/L/kg) as compared with
DM+ATH pigs (1.60±0.13 μmol/L/kg, p<0.01) group. However, urinary albumin/creatinine
ratio was not found to differ between the DM+ATH group (0.045±0.0182 mg/mmol) and ATH
pigs (0.002±0.0007 mg/mmol, p>0.05).
Fig 1. Early atherogenic DM leads to increased capillary tortuosity. A. Sidestream darkfield images of the oral mucosa visualizing the microvascular
capillaries of a representative pig in the Controls, ATH and DM+ATH group. B. Mean tortuosity index of microvascular capillaries in the Controls (n = 7), ATH
(n = 5) and DM+ATH pigs (n = 5). C. Mean vessel density (capillaries/mm2) in Controls (n = 7), ATH (n = 5) and DM+ATH (n = 5) pigs. Data shown are mean
±SEM. *P<0.05 compared to Controls or ATH pigs. Mean vessel density (capillaries/mm2) was calculated by evaluation of number of vessels per selected
microcirculatory image. Subsequently, tortuosity of capillary loops was assessed according to a validated scoring system (0: no twists to 4: four or more
twists) and the average of assessed capillary tortuosity was used to calculate mean tortuosity index per patient.
doi:10.1371/journal.pone.0121555.g001
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PAS-stained renal sections revealed marked tubular changes with foamy cytoplasm and hy-
alin droplets in all DM+ATH pigs and there were glomerular lesions consisting of mesangial
expansion and podocyte lesions, also with foamy cytoplasm and hyaline droplets in four DM
+ATH pigs (Fig 2A). In contrast, but one ATH pig displayed similar lesions (Fig 2A). Some
glomeruli were found to have dilated capillaries containing numerous red blood cells, a phe-
nomenon that is highly reminiscent of microangiopathic injury lesions that have been de-
scribed to be the result of fibrinolytic/proteolytic activation system in combination with
increased PAI-1 staining [25]. In keeping with this notion, we observed both co-localization
and increased PAI-1 staining in the herein described lesions (Fig 2A).
Next, we determined the mesangial expansion index in renal cross-sections. These studies
showed significantly higher scores in the ATH pigs (0.62±0.05, p = 0.03) and a trend towards
increased scores in the DM+ATH (0.58±0.05,p = 0.066) compared with the Controls (0.49
±0.03; Fig 2B). Interestingly, the width of the GBM increased from 215 nM in a Controls ani-
mal to 252 and 279 nM in cases with mild and severe DN of the DM+ATH group, respectively.
Moreover, lipid deposits were observed in kidneys of mild and severe DN pigs (Fig 2C).
Diabetes and atherogenic diet induces Angpt2/Angpt1dysbalance in
pigs
Serum Angpt-1 levels in the DM+ATH pigs were increased as compared to control pigs (26035
±1228 pg/ml versus 18061±1228 pg/ml, p<0.01). There were no significant differences in
serum Ang-1 levels between DM+ATH and ATH pigs (19832±1166 pg/ml, p>0.05). Angpt-2
levels were not detectable in the circulation of the different groups.
With regard to Angpt1 staining in the kidneys, we observed positive Angpt1 staining in the
glomeruli and in a capillary-like pattern between the tubuli of pigs in the Controls group (Fig
3A). We found no difference in renal Angpt1 protein expression between ATH (78020±12216
pixels/area) and DM+ATH (46763±12360 pixels/area, p>0.05) pigs, but Angpt1expression
was significantly higher in the Controls group (91788±9777 pixels/area, p< 0.05; Fig 3A). The
Angpt1mRNA levels in the kidney were significantly lower in the DM+ATH and ATH group
compared with the Controls pigs (Fig 3D). Double staining of Angpt1 and the pericyte marker
desmin revealed predominantly expression of desmin in the glomeruli and Angpt1 expression
in the same pattern as described above (Fig 3B; left panel). However, no co-localization was ob-
served, suggesting that other cells than pericytes might produce Angpt1 in the glomerulus.
Angpt2 staining was predominantly present in glomeruli and tubuli (Fig 3A) and showed a
significant increase in DM+ATH (54813±3140 pixels/area) pigs compared to the Controls
(22862±3354 pixels/area, p<0.001) and ATH (31005±5011 pixels/area, p<0.01) pigs (Fig 3C).
Consequently, a higher Angpt2/ Angpt1ratio was observed in DM+ATH (1.63±0.43) pigs com-
pared with Controls (0.28±0.07, p<0.001) and ATH (0.43±0.07, p<0.01) group (Fig 3C). The
Angpt2 mRNA levels in the kidney did not significantly differ between groups (Fig 3D). Impor-
tantly, additional staining of vWF and Angpt2 revealed co-expression, suggesting that endothe-
lial cells produce Angpt2 (Fig 3B; middle and right panel).
Staining of the endothelial marker vWF showed expression in the glomeruli and peritubular
space, in the same pattern as Angpt1 (Fig 4A). No significant differences were observed in
vWF expression between the Controls (86611±6163 pixels/area), ATH (84547±9000 pixels/
area) and DM+ATH pigs (102961±13633 pixels/area) (p>0.05).
VEGF-A staining revealed expression in podocytes, parietal epithelial cells and tubuli (most
extensively) in all groups (Fig 4B). There was no difference in VEGF-A expression between the
DM+ATH (16.94±0.72), ATH (21.22±2.30) and Controls (20.70±1.24) (p 0.05).
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Fig 2. Early stages of atherogenic DM leads to renal damage. A: Representative illustration of PAS stained glomeruli from a DM+ATH pig, showing
mesangial proliferation and matrix expansion with capillary loops lying around the mesangium as a corona, reminiscent of a beginning Kimmelstiel-Wilson
nodule (left panel; thin black arrow). Dilated capillary loops with red cell fragments show intense PAI-1 staining on consecutive slides (right panel; thick black
arrow). B: Mesangial expansion index in Controls (n = 7), ATH (n = 5) and DM+ATH (n = 5) pigs. C. Electron microscopy images illustrating a normal GBM
architecture (left panel; thick arrow) of the Controls pig. In ATH, there is slight effacement of the podocyte pedicles (middle panel; thick arrow). In DM+ATH,
marked lipid deposits were found (right panel). Data are shown as mean ± SEM. *P<0.05 compared to Controls or ATH pigs. Original magnification of A:
x400 and C: x8000.
doi:10.1371/journal.pone.0121555.g002
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Angpt2/Angpt1 dysbalance and creatinine levels are correlated with
capillary tortuosity
Correlation analyses were performed between renal Angpt1, Angpt2, Angpt2/Angpt1ratio, creat-
inine levels and albumin/creatinine ratio and oral mucosal capillary tortuosity and density indi-
ces. No correlation was found between capillary density index and renal angiopoietin expression
or urinary markers for renal function. However, a negative correlation was found between renal
Angpt1expression and microvascular tortuosity index (r = -0.60, p = 0.0100; Fig 5A). Moreover,
we demonstrated a positive correlation between capillary tortuosity and Angpt2 staining
(r = 0.70, p = 0.0017; Fig 5B) and Angpt2/Angpt1ratio (r = 0.80, p = 0.0002; Fig 5C).
No significant correlation was found between urinary albumin/creatinine ratio, creatinine
levels and capillary tortuosity index.
Fig 3. The Angpt2/Angpt1 balance is disturbed in atherogenic DM pigs. A. Representative illustrations of kidney sections stained with Angpt1 (upper
panels; arrow: glomerulus; arrowhead: peritubular area) or Angpt2 (lower panels; arrow: glomerulus; arrowhead: tubular staining) in Controls, ATH, and DM
+ATH pigs. B. Immunofluorescent double staining of representative kidney sections for desmin (green)/Angpt1 (red;left panel) and vWF (green/Angpt2 (red;
middle/right panel). Insets: double positivity for vWF/Angpt2 staining in yellow. C: Quantitative analysis of renal expression of Angpt1, Angpt2 and Angpt2/
Angpt1 ratio. D. Relative mRNA expression of Angpt1 and Angpt2. Data are shown as mean ± SEM. *P<0.05 compared to Controls or ATH pigs. Original
magnification of A and B: x400.
doi:10.1371/journal.pone.0121555.g003
Fig 4. No difference in renal vWf and VEGF-A expression. A. Representative illustrations of kidney sections stained with endothelial marker vWF (arrow:
glomerulus; arrowhead: peritubular area) in Controls, ATH, and DM+ATH pigs. B. Representative images of kidney sections stained with VEGF in Controls,
ATH, and DM+ATH pigs showing expression in podocytes (arrow head), parietal epithelial cells (thin arrow) and tubuli (asterix). Original magnification of A: x
200 and B: x400.
doi:10.1371/journal.pone.0121555.g004
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Discussion
In the present study, we show that the combination of an atherogenic diet and recent onset of
DM leads to abnormalities in the systemic microvasculature, yielding SDF-detectable increases
in capillary tortuosity and increased levels of serum Angpt1. Furthermore, we discovered that
glomerular lesions develop during the early stages of DN and that the tight control of the
Angpt2/Angpt1balance is perturbed in the kidneys of diabetic atherogenic pigs.
Microvascular dysfunction is one of the most important causes of persistent diabetic com-
plications. This is the result of disturbed hemodynamics and impaired endothelial function in-
duced by metabolic alterations [26,27]. However, the early events involved in the pathogenesis
of diabetic microvascular complications are not well understood, and are difficult to study in
humans without the use of invasive techniques. SDF imaging allows for the easy, and rapid as-
sessment of the presence of systemic microvascular derangements that could precede the devel-
opment of diabetic macrovascular complications. In our study, we observed increased capillary
tortuosity between the DM+ATH and ATH groups, already at ~15 months following DM in-
duction. Using SDF imaging, we recently demonstrated increased capillary tortuosity in diabe-
tes patients, and reversal of microvascular tortuosity after simultaneous pancreas-kidney
transplantation [16]. Moreover, we have previously shown that increased capillary tortuosity in
diabetic patients was associated with macrovascular disease [10]. In concordance with our ob-
servations, Sasongko et al demonstrated increased tortuosity in patients with diabetic retinopa-
thy, suggesting that this may be an early sign of microvascular damage in DM [28,29].
However, these studies did not include patients with early stage DM and did not focus on the
role of angiopoietins in microvascular alterations and renal injury in atherogenic DM.
In addition to increased microvascular tortuosity, we also observed increased serum levels
of Angpt-1 in DM+ATH pigs compared with the control group. These data are in line with
previous clinical studies in patients with moderate and severe non-proliferative diabetic reti-
nopathy [30] and in patients with hypertension [31] that showed increased Angpt1 serum lev-
els in these patients as well. While serum Angpt1 levels were increased in DM+ATH pigs, we
found a decrease in Angpt1 protein and mRNA expression in kidneys of diabetic pigs com-
pared to control groups. This observation suggests shedding of Angpt1 from renal vasculature
into the circulation.
Interestingly, DM+ATH pigs were characterized by higher expression levels of Angpt2 pro-
tein as compared to the ATH group, resulting in a higher Angpt2/ Angpt1 ratio in the DM
+ATH pigs. This is in agreement with Rizkalla and co-workers, who previously have shown
Fig 5. Correlation between capillary tortuosity and Angpt2/Angpt1balance and creatinine levels. Scatter plot showing the correlation of renal protein
expression of Angpt1(A), Angpt2 (B), Angpt2/Angpt1ratio (C).
doi:10.1371/journal.pone.0121555.g005
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that both Angpt1 and Angpt2 protein levels are increased in the early phase of STZ-induced
DM in rats [32]. However, disease progression was found to trigger a decrease in Angpt1ex-
pression while Angpt2 continued to increase, a switch that both markedly alters but also dis-
turbs the Angpt2/Angpt1balance [32]. Although a difference in angiopoietin expression
between rats and pigs cannot be excluded, these findings suggest that angiopoietins undergo
time-dependent changes in expression at different stages of DM. Our identification that an in-
creased urinary albumin/creatinine ratio is associated with a higher Angpt2/Angpt1 ratio (in
DM+ATH pigs) is in keeping with recent studies that demonstrated an inability to express
Angpt1 leads to extensive glomerular damage and proteinuria, indicating a protective role of
Angpt1[33]. These data suggest that angiopoietins might play an important role in the patho-
physiology of glomerular disease in DN.
Aside from angiopoietins, numerous other mechanisms have been proposed to be causal for
microvascular complications in DM, such as VEGF. Under pathological conditions, Angpt2
acts in concert with VEGF to induce inflammatory angiogenesis. By promoting pericyte drop-
out, Angpt2 will lead to destabilization between ECs and pericytes. In the presence of VEGF,
Angpt2 can eventually lead to an active, sprouting state of ECs, but when VEGF is absent,
Angpt2 promotes vessel regression [34–36]. Our immunohistochemical assessment of VEGF
protein in the different groups revealed high expression levels in podocytes and parietal—and
tubular epithelial cells, which is in keeping with literature [34,37–40]. However, in contrast to
previous studies, we did not observe differences between the different groups.
An additional observation we made was the marked increase in PAI-1 expression in regions
of microvascular injury. PAI-1, a protease and fibrinolysis inhibitor that is poorly expressed in
healthy kidneys, which is a critical player in angiogenesis and vascular remodeling [41]. Previ-
ous studies in rats and humans by the group of Fogo have shown that the expression level of
PAI-1 in normal glomeruli is low and increases in pathological conditions, such as diabetic ne-
phropathy [25,42].
Our observation that glomerular and tubular expression of PAI-1 is increased in DM+ATH
pigs is noteworthy due to the fact that: 1) PAI-1 was found to be prominently expressed in
Kimmelstiel-Wilson nodules, in particular those with active microvascular damage [25]; 2)
unilateral ureteral obstruction [43] and glomerulonephritis [44] have also been associated with
increased expression of tubular PAI-1; and 3) endogenous PAI-1 deficiency protects diabetic
mice from glomerular injury [45]. Collectively, these data support for a pathogenic role for
PAI-1 in diabetic renal disease.
In the current study, there was a tendency towards increased mesangial expansion in the
DM+ATH pigs, and significantly more mesangial expansion in kidneys of ATH pigs. The data
confirm previous reports on pig studies which revealed that consumption of high-fat diet leads
to the development of renal injury, characterized by mesangial expansion and increased plasma
creatinine levels [46,47]. Moreover, rodent studies demonstrated that hyperlipidemia exacer-
bates the development and progression of renal diseases, including DN [48,49]. Furthermore,
our study also showed higher creatinine levels in the ATH group than the DM+ATH and Con-
trols, which could be explained by the increased mesangial expansion observed in ATH pigs.
The latter has been associated with obliteration of capillary lumen and decreased capillary per-
fusion in previous studies [50]. Furthermore, our study suggests that the combined hyperglyce-
mia and hyperlipidemia in the DM +ATH pigs, induces a dysbalance in renal angiopoietins
that results in albuminuria and endothelial damage in the kidney. The potential contribution
of tubular injury to albuminuria needs to be addressed in additional studies.
Some aspects of our porcine study require further discussion. First, it would have been inter-
esting to study an additional group of pigs with only diabetes (i.e. without ATH) to explore the
early effects of only hyperglycemia on the microvasculature. However, the clinically most
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relevant group of DN also reflects DM patients with some presence of atherosclerosis as well.
Secondly, it could be argued that the differences in gender, age and weight between healthy
control pigs (Controls) versus DM+ATH and ATH pigs may explain part of the difference in
the observed capillary tortuosity between these groups. This is, however, unlikely as in a
human study, age did not influence capillary tortuosity [16].
In conclusion, we present SDF imaging as a novel means of documenting capillary tortuosi-
ty, an event that is illustrative of renal injury in the setting of early DM and atherosclerosis.
This technique enables one to non-invasively detect systemic microvascular damage. Further-
more, we also identified changes in the Angpt2/Angpt1 balance may represent initiating events
of renal injury in early DM. We propose that the targeted intervention of angiopoietins signal-
ing could be an effective modality in minimizing microvascular damage that could serve as an
early initiator of DN.
Acknowledgments
Eric van der Veer is greatly acknowledged for carefully reading the manuscript and providing
constructive comments.
Author Contributions
Conceived and designed the experiments: JR TR MKWvdGMR. Performed the experiments:
MK RdB MvdH OS. Analyzed the data: MK RdB HBMZ IB. Contributed reagents/materials/
analysis tools: DD BvdB NSvD. Wrote the paper: JR MKMvdH.
References
1. Cumbie BC, Hermayer KL. Current concepts in targeted therapies for the pathophysiology of diabetic
microvascular complications. Vasc Health Risk Manag. 2007; 3: 823–32. PMID: 18200803
2. Tooke JE. Microvasculature in diabetes. Cardiovasc Res. 1996; 32: 764–71. PMID: 8915194
3. Feng D, Bursell SE, Clermont AC, Lipinska I, Aiello LP, Laffel L, et al. vonWillebrand factor and retinal
circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care. 2000; 23: 1694–8. PMID:
11092294
4. Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G. Increased plasmamarkers of inflammation and
endothelial dysfunction and their association with microvascular complications in Type 1 diabetic pa-
tients without clinically manifest macroangiopathy. Diabet Med. 2005; 22: 999–1004. PMID: 16026364
5. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immu-
nol. 2006; 27: 552–8. PMID: 17045842
6. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, et al. Pericytes and the pathogenesis
of diabetic retinopathy. Diabetes. 2002; 51: 3107–12. PMID: 12351455
7. Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classifi-
cation of diabetic nephropathy. J Am Soc Nephrol. 2010; 21: 556–63. doi: 10.1681/ASN.2010010010
PMID: 20167701
8. Edwards MS, Wilson DB, Craven TE, Stafford J, Fried LF, Wong TY, et al. Associations between retinal
microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular
Health Study. Am J Kidney Dis. 2005; 46: 214–24. PMID: 16112039
9. Goedhart PT, Khalilzada M, Bezemer R, Merza J, Ince C. Sidestream Dark Field (SDF) imaging: a
novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation.
Opt Express. 2007; 15: 15101–14. PMID: 19550794
10. Djaberi R, Schuijf JD, de Koning EJ, Wijewickrama DC, Pereira AM, Smit JW, et al. Non-invasive as-
sessment of microcirculation by sidestream dark field imaging as a marker of coronary artery disease in
diabetes. Diab Vasc Dis Res. 2012.
11. Kilkenny C, BrowneWJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting:
the ARRIVE guidelines for reporting animal research. Osteoarthritis Cartilage. 2012; 20: 256–60. doi:
10.1016/j.joca.2012.02.010 PMID: 22424462
12. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine.
Diabetes. 2001; 50: 1654–65. PMID: 11423488
Microvascular Damage in Atherogenic Diabetes Mellitus Angiopoietins
PLOS ONE | DOI:10.1371/journal.pone.0121555 April 24, 2015 13 / 15
13. van den Heuvel M, Sorop O, Koopmans SJ, Dekker R, de VR, van BeusekomHM, et al. Coronary mi-
crovascular dysfunction in a porcine model of early atherosclerosis and diabetes. Am J Physiol Heart
Circ Physiol. 2012; 302: H85–H94. doi: 10.1152/ajpheart.00311.2011 PMID: 21984550
14. Koopmans SJ, Mroz Z, Dekker R, Corbijn H, Ackermans M, Sauerwein H. Association of insulin resis-
tance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in
a type 2-like diabetic pig model. Metabolism. 2006; 55: 960–71. PMID: 16784971
15. Koopmans SJ, Dekker R, Ackermans MT, Sauerwein HP, Serlie MJ, van BeusekomHM, et al. Dietary
saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early
atherosclerosis and ectopic fat deposition in diabetic pigs. Cardiovasc Diabetol. 2011; 10: 64. doi: 10.
1186/1475-2840-10-64 PMID: 21756316
16. Khairoun M, de Koning EJ, van den Berg BM, Lievers E, de Boer HC, Schaapherder AF, et al. Micro-
vascular damage in type 1 diabetic patients is reversed in the first year after simultaneous pancreas-
kidney transplantation. Am J Transplant. 2013; 13: 1272–81. doi: 10.1111/ajt.12182 PMID: 23433125
17. KhairounM, van der Pol P, de Vries DK, Lievers E, Schlagwein N, de Boer HC, et al. Renal ischemia-re-
perfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibro-
sis. Am J Physiol Renal Physiol. 2013; 305: F901–F910. doi: 10.1152/ajprenal.00542.2012 PMID:
23825073
18. David S, Kumpers P, Hellpap J, Horn R, Leitolf H, Haller H, et al. Angiopoietin 2 and cardiovascular dis-
ease in dialysis and kidney transplantation. Am J Kidney Dis. 2009; 53: 770–8. doi: 10.1053/j.ajkd.
2008.11.030 PMID: 19268412
19. David S, Kumpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Boger SM, et al. Circulating
angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant. 2010;
25: 2571–6. doi: 10.1093/ndt/gfq060 PMID: 20179005
20. Sugaru E, Sakai M, Horigome K, Tokunaga T, Kitoh M, HumeWE, et al. SMP-534 inhibits TGF-beta-in-
duced ECM production in fibroblast cells and reduces mesangial matrix accumulation in experimental
glomerulonephritis. Am J Physiol Renal Physiol. 2005; 289: F998–1004. PMID: 15900023
21. Sugaru E, Nakagawa T, Ono-Kishino M, Nagamine J, Tokunaga T, Kitoh M, et al. SMP-534 ameliorates
progression of glomerular fibrosis and urinary albumin in diabetic db/db mice. Am J Physiol Renal Phy-
siol. 2006; 290: F813–F820. PMID: 16278277
22. Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA, et al. Anti-C1q autoantibodies
deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune
complexes. J Clin Invest. 2004; 114: 679–88. PMID: 15343386
23. van der Pol P, Schlagwein N, van Gijlswijk DJ, Berger SP, Roos A, Bajema IM, et al. Mannan-binding
lectin mediates renal ischemia/reperfusion injury independent of complement activation. Am J Trans-
plant. 2012; 12: 877–87. doi: 10.1111/j.1600-6143.2011.03887.x PMID: 22225993
24. van Ditzhuijzen NS, van den Heuvel M, Sorop O, van Duin RW, Krabbendam-Peters I, van HR, et al. In-
vasive coronary imaging in animal models of atherosclerosis. Neth Heart J. 2011; 19: 442–6. doi: 10.
1007/s12471-011-0187-0 PMID: 21904848
25. Paueksakon P, Revelo MP, Ma LJ, Marcantoni C, Fogo AB. Microangiopathic injury and augmented
PAI-1 in human diabetic nephropathy. Kidney Int. 2002; 61: 2142–8. PMID: 12028454
26. Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk
Manag. 2008; 4: 1061–8. PMID: 19183753
27. Kuryliszyn-Moskal A, Dubicki A, Zarzycki W, Zonnenberg A, Gorska M. Microvascular abnormalities in
capillaroscopy correlate with higher serum IL-18 and sE-selectin levels in patients with type 1 diabetes
complicated by microangiopathy. Folia Histochem Cytobiol. 2011; 49: 104–10. PMID: 21526496
28. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ. Retinal vascular tortuosity in
persons with diabetes and diabetic retinopathy. Diabetologia. 2011; 54: 2409–16. doi: 10.1007/s00125-
011-2200-y PMID: 21625945
29. Sasongko MB, Wong TY, Donaghue KC, Cheung N, Jenkins AJ, Benitez-Aguirre P, et al. Retinal arteri-
olar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am J
Ophthalmol. 2012; 153: 176–83. doi: 10.1016/j.ajo.2011.06.005 PMID: 21907319
30. Patel JI, Hykin PG, Gregor ZJ, Boulton M, Cree IA. Angiopoietin concentrations in diabetic retinopathy.
Br J Ophthalmol. 2005; 89: 480–3. PMID: 15774928
31. Nadar SK, Blann A, Beevers DG, Lip GY. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and
vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-
study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med. 2005; 258: 336–43.
PMID: 16164572
Microvascular Damage in Atherogenic Diabetes Mellitus Angiopoietins
PLOS ONE | DOI:10.1371/journal.pone.0121555 April 24, 2015 14 / 15
32. Rizkalla B, Forbes JM, Cao Z, Boner G, Cooper ME. Temporal renal expression of angiogenic growth
factors and their receptors in experimental diabetes: role of the renin-angiotensin system. J Hypertens.
2005; 23: 153–64. PMID: 15643138
33. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, et al. Angiopoietin-1 is essential
in mouse vasculature during development and in response to injury. J Clin Invest. 2011; 121: 2278–89.
doi: 10.1172/JCI46322 PMID: 21606590
34. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003; 9: 685–93. PMID: 12778167
35. Kim KL, Shin IS, Kim JM, Choi JH, Byun J, Jeon ES, et al. Interaction between Tie receptors modulates
angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc Res. 2006; 72: 394–402.
PMID: 17054925
36. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary struc-
ture and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002; 99: 11205–10. PMID:
12163646
37. Baelde HJ, Eikmans M, Doran PP, Lappin DW, de HE, Bruijn JA. Gene expression profiling in glomeruli
from human kidneys with diabetic nephropathy. Am J Kidney Dis. 2004; 43: 636–50. PMID: 15042541
38. Baelde HJ, Eikmans M, Lappin DW, Doran PP, Hohenadel D, Brinkkoetter PT, et al. Reduction of
VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int.
2007; 71: 637–45. PMID: 17264876
39. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, et al. Increased renal expression of
vascular endothelial growth factor (VEGF and its receptor VEGFR-2 in experimental diabetes. Diabe-
tes. 1999; 48: 2229–39. PMID: 10535459
40. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP. Local VEGF activity but not
VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 2006; 69: 1654–
61. PMID: 16541023
41. Stefansson S, McMahon GA, Petitclerc E, Lawrence DA. Plasminogen activator inhibitor-1 in tumor
growth, angiogenesis and vascular remodeling. Curr Pharm Des. 2003; 9: 1545–64. PMID: 12871067
42. Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB. Plasminogen activator inhibitor-1 expression
is regulated by the angiotensin type 1 receptor in vivo. Kidney Int. 2000; 58: 251–9. PMID: 10886570
43. Ishidoya S, Ogata Y, Fukuzaki A, Kaneto H, Takeda A, Orikasa S. Plasminogen activator inhibitor-1
and tissue-type plasminogen activator are up-regulated during unilateral ureteral obstruction in adult
rats. J Urol. 2002; 167: 1503–7. PMID: 11832778
44. Barnes JL, Mitchell RJ, Torres ES. Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellu-
lar remodeling in proliferative glomerulonephritis in the rat. J HistochemCytochem. 1995; 43: 895–905.
PMID: 7642963
45. Lassila M, Fukami K, Jandeleit-Dahm K, Semple T, Carmeliet P, Cooper ME, et al. Plasminogen activa-
tor inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease. Diabetologia.
2007; 50: 1315–26. PMID: 17415547
46. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, et al. Structural and functional changes in
the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 2009; 296: F118–F126.
doi: 10.1152/ajprenal.00110.2008 PMID: 18971213
47. Taneja D, Thompson J, Wilson P, Brandewie K, Schaefer L, Mitchell B, et al. Reversibility of renal injury
with cholesterol lowering in hyperlipidemic diabetic mice. J Lipid Res. 2010; 51: 1464–70. doi: 10.1194/
jlr.M002972 PMID: 20110440
48. Thompson J, Wilson P, Brandewie K, Taneja D, Schaefer L, Mitchell B, et al. Renal accumulation of
biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol. 2011; 179: 1179–87. doi:
10.1016/j.ajpath.2011.05.016 PMID: 21723246
49. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insights from experimental
data and clinical studies. Diabetes Metab. 2000; 26: 254–64. PMID: 11011217
50. Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss
of kidney function in diabetic patients. Diabetes. 1989; 38: 1077–81. PMID: 2670639
Microvascular Damage in Atherogenic Diabetes Mellitus Angiopoietins
PLOS ONE | DOI:10.1371/journal.pone.0121555 April 24, 2015 15 / 15
